UnitedHealth, stock up 5.14% · EPS 18.25dollars higher

UnitedHealth Group shares rose 5.14% in Thursday trading. The stock move occurred as changes in assessments by investment institutions coincided with a change in the company's earnings outlook. The increase was observed both intraday and at the close.

BofA Securities raised its price target for UnitedHealth to 450 dollars. Morgan Stanley also raised its price target to 453 dollars. The price-target increases by the two institutions stimulated buying sentiment.

The announcement of Medicare Advantage-related payment rates in the United States included a 2027 payment rate increase of 2.48%. The announcement stated that the payment standards applicable for that year would be adjusted. The news was presented as a factor affecting the earnings environment for managed insurers as a whole.

The company said 2026year adjusted earnings per share guidance was raised to 18.25dollars or more. The guidance increase was part of the company’s latest earnings outlook. The announcement drew investor interest that day.

The market reportedly attributed the share-price increase to the simultaneous reflection of an upward revision to the investment institution’s price target, the announcement of Medicare reimbursement rates, and the company’s raised guidance. The related disclosure can be confirmed through the company’s regular filings. Further changes should be confirmed through materials released later.